Research News at Hollings

Pursuing bold ideas against rare and aggressive childhood cancer

a researcher working at a lab bench

Treatments for Ewing sarcoma have been essentially the same for more than 30 years. Casey Langdon, Ph.D., wants to change that. His lab is using a St. Baldrick’s Foundation Scholar Grant to investigate safer, improved combination therapies for this aggressive childhood bone cancer.

“If you give one drug that forces the cancer cells to rely on a new pathway, and then hit that pathway with a second drug, the combination can be very powerful,” he said.

Read about the research

A cancer researcher watches as a student works in her lab

NCI Fellowship

MUSC student Thomas Blouin will use an NCI fellowship to study how a chemical that doesn't seem to change DNA still causes cancer.

HPV public health researcher Kalyani "Kelly" Sonawane

HPV-Cancer Connection

Many people remain unaware that HPV can cause six types of cancer – and that can affect whether people choose to vaccinate.

HPV cancers public health researcher Dr. Trisha Amboree poses at Hollings Cancer Center

Cervical Cancer Screening

Counties with historically lower rates of screening for cervical cancer have higher rates of late-stage diagnosis and death.

image of natural language processing researcher Jihad Obeid

Using AI to Improve Care

Details in medical record notes are often critical to proper care. AI can help highlight those notes as patients move among doctors in different specialties.

Stressing T-cells

Hollings researcher Dr. Shikhar Mehrotra received two NCI grants to improve T-cells functioning against cancer.

a woman in lab coat and gloves sits at a console

Leukemia Research

A Hollings researcher led a group that developed an immunotherapy to target leukemia stem cells; they hope to move to clinical trials soon.

a young woman covered in lab coat and gloves works under a hood in a science lab

St. Baldrick's Fellowship

An undergrad is spending her summer studying pediatric sarcoma in the lab of Dr. Casey Langdon, thanks to a grant from the St. Baldrick's Foundation.

researchers pose in a scientific lab

Drug Development

Researchers at MUSC Hollings Cancer Center are working to develop new drug combinations for people with treatment-resistant cancer.

portrait of a cancer researcher in a garden

Anal Cancer Screening

A new modeling study provides insight for guideline-writing bodies on who should be screened for anal cancer, how often and with which method.